Robert J. Snijder
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Prevalence of Elevated Liver-Associated Enzymes in Women Aged 40-65 Years in the United States Overall, and With and Without Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Journal of women's health (2002)
Published: June 16, 2026
Treatment patterns of hormone therapy for menopause-associated vasomotor symptoms: analysis of the HIRA database in South Korea.
Journal: Climacteric : the journal of the International Menopause Society
Published: February 11, 2026
Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349].
Journal: European urology oncology
Published: December 31, 2025
Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9.
Journal: World journal of urology
Published: November 05, 2025
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group.
Journal: European urology open science
Published: September 19, 2025
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis.
Journal: European urology oncology
Published: August 04, 2025
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Journal: European urology focus
Published: May 25, 2025
Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study.
Journal: World journal of urology
Published: May 15, 2025
Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England.
Journal: JCO oncology practice
Published: April 21, 2025
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.
Journal: Nature reviews. Urology
Published: June 11, 2024
Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study.
Journal: Advances in therapy
Published: June 10, 2024
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Journal: European urology open science
Published: February 28, 2024
Last Updated: 09/26/2026